Acetyl starchAlternative Names: Acetylamylopectin; ACS
Latest Information Update: 26 Apr 2004
At a glance
- Originator Braun Melsungen; Johann Wolfgang Goethe Universitatsklinikum
- Class Plasma expanders
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hypovolaemia
Most Recent Events
- 26 Apr 2004 Discontinued - Phase-II for Hypovolaemia in Germany (IV-infusion)
- 30 Aug 2000 Phase-II clinical trials for Hypovolaemia in Germany (IV-infusion)